ProPhase Labs, Inc. (PRPH) Financials
PRPH Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 59.9 million | 56.4 million |
| Dec. 31, 2025 | 59.9 million | 56.4 million |
| Sept. 30, 2025 | 65.7 million | 58.8 million |
| June 30, 2025 | 42.0 million | 30.6 million |
PRPH Free Cash Flow and Stock based compensation
No data available :(
PRPH Net Income
No data available :(
PRPH Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 90000 | - | - |
| Dec. 31, 2025 | 90000 | - | 3.5 million |
| Sept. 30, 2025 | 405000 | - | 965000 |
| June 30, 2025 | 171000 | 436000 | 1.9 million |
PRPH Shares Outstanding
PRPH Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | - | 6.0 million | - |
| Dec. 31, 2025 | - | - | 6.0 million | - |
| Sept. 30, 2025 | - | 6000 | 4.1 million | - |
| June 30, 2025 | - | 4000 | 4.6 million | - |
PRPH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 784000 | 537000 |
| Dec. 31, 2025 | 784000 | 537000 |
| Sept. 30, 2025 | 883000 | 1.0 million |
| June 30, 2025 | 1.2 million | 513000 |
PRPH Revenue by Segment
Graph available only for paid members. Upgrade to see it.
PRPH
Price: $0.06
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.75 USD
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 65100
Ebitda: -2.3 millionMarket Capitalization: 342486
Average Dividend Frequency: 1